Table 2.
Reproducibility coefficient (RDC*) grades for reproducibility
Grade | Upper value of 95% CI for RDC* | Segmentation | Administered activity | Whole liver volume | Whole liver absorbed dose | Whole liver normal tissue volume | Whole liver NTAD | Perfused normal tissue volume | Perfused NTAD | Total perfused tumour volume | Total perfused TAD |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | < 1.5 | Anatomic | X | X | X | ||||||
99mTc-MAA SPECT | |||||||||||
2 | ≥ 1.5 and < 2 | Anatomic | X | ||||||||
99mTc-MAA SPECT | X | X | |||||||||
3 | ≥ 2 and < 3 | Anatomic | X | X | X | X | |||||
99mTc-MAA SPECT | X | X | |||||||||
4 | ≥ 3 | Anatomic | X | ||||||||
99mTc-MAA SPECT | X | X | X | X | X |
CI, confidence interval; RDC, reproducibility coefficient; 99mTc-MAA, technetium-99m macroaggregated albumin; NTAD, normal tissue absorbed dose; SPECT, single-photon emission computed tomography; TAD, tumour absorbed dose
*Corresponding to the maximum fold difference in the measurement from two different reviewers in 95% of cases